(Q53669998)

17 May 2018

title

Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing. (English)

1 reference

17 May 2018

1 reference

Fredrik Agholme

1

1 reference

17 May 2018

Brandon Macias

2

1 reference

17 May 2018

Matt Hamang

3

1 reference

17 May 2018

Jonathan Lucchesi

4

1 reference

17 May 2018

Mary D Adrian

5

1 reference

17 May 2018

Stuart Kuhstoss

6

1 reference

17 May 2018

Anita Harvey

7

1 reference

17 May 2018

Masahiko Sato

8

1 reference

17 May 2018

Per Aspenberg

9

1 reference

17 May 2018

publication date

14 November 2013

1 reference

17 May 2018

Journal of Orthopaedic Research

published in

1 reference

17 May 2018

volume

32

1 reference

17 May 2018

issue

3

1 reference

17 May 2018

page(s)

471-476

1 reference

17 May 2018

Small animal bone healing models: standards, tips, and pitfalls results of a consensus meeting

cites work

1 reference

Surface-bound bisphosphonates enhance screw fixation in rats--increasing effect up to 8 weeks after insertion.

21 January 2018

1 reference

Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats.

21 January 2018

1 reference

Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.

21 January 2018

1 reference

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

21 January 2018

1 reference

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

21 January 2018

1 reference

Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing

21 January 2018

1 reference

The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals

21 January 2018

1 reference

The natural history of sclerosteosis

21 January 2018

1 reference

Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease

21 January 2018

1 reference

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

21 January 2018

1 reference

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor

21 January 2018

1 reference

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures

21 January 2018

1 reference

Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).

21 January 2018

1 reference

Teriparatide improves early callus formation in distal radial fractures

21 January 2018

1 reference

Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women

21 January 2018

1 reference

Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation

21 January 2018

1 reference

Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH

21 January 2018

1 reference

Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice

21 January 2018

1 reference

Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function

21 January 2018

1 reference

Bone mineral density in sclerosteosis; affected individuals and gene carriers

21 January 2018

1 reference

Sclerostin in Mineralized Matrices and van Buchem Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JOR.22525

1 reference

17 May 2018

1 reference

17 May 2018